Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates

Century Therapeutics, Inc. (IPSC) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of$ 0.45. This compares to loss of $0.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.44%. A quarter ago, it was expected that this company would post a loss of$ 0.46 per share when it actually produced a loss of $0.37, delivering a surprise of 19.57%.Over the last four quarters, the company ha ...